Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-13-002974
Filing Date
2013-03-18
Accepted
2013-03-18 16:45:15
Documents
15
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2213642z10-k.htm 10-K 1080287
2 EX-23.1 a2213642zex-23_1.htm EX-23.1 6414
3 EX-31.1 a2213642zex-31_1.htm EX-31.1 8502
4 EX-31.2 a2213642zex-31_2.htm EX-31.2 8517
5 EX-32.1 a2213642zex-32_1.htm EX-32.1 8998
12 G244313.JPG g244313.jpg GRAPHIC 103496
13 G29602.JPG g29602.jpg GRAPHIC 85201
14 G381554.JPG g381554.jpg GRAPHIC 110023
15 G877176.JPG g877176.jpg GRAPHIC 56679
  Complete submission text file 0001047469-13-002974.txt   10554565

Data Files

Seq Description Document Type Size
6 EX-101.INS astx-20121231.xml EX-101.INS 1357234
7 EX-101.SCH astx-20121231.xsd EX-101.SCH 80525
8 EX-101.CAL astx-20121231_cal.xml EX-101.CAL 134914
9 EX-101.LAB astx-20121231_lab.xml EX-101.LAB 1395190
10 EX-101.PRE astx-20121231_pre.xml EX-101.PRE 733464
11 EX-101.DEF astx-20121231_def.xml EX-101.DEF 461659
Mailing Address 4140 DUBLIN BLVD STE 200 DUBLIN CA 94568
Business Address 4140 DUBLIN BLVD SUITE 200 DUBLIN CA 94568 9255600100
Astex Pharmaceuticals, Inc (Filer) CIK: 0000919722 (see all company filings)

EIN.: 911841574 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-27628 | Film No.: 13698205
SIC: 2834 Pharmaceutical Preparations